Abstract
Abnormal placental vasculature is associated with preeclampsia. Preeclampsia is of two types, i.e., early- and late-onset preeclampsia (LOP), both having different etiologies. We have earlier demonstrated low levels of omega-3 fatty acids and vitamin E in women with preeclampsia. The current study examines the effect of maternal omega-3 fatty acids and vitamin E supplementation on angiogenic factors in a rat model of preeclampsia. Pregnant rats were divided into a total of five groups control, early-onset preeclampsia (EOP); LOP; EOP supplemented with omega-3 fatty acid and vitamin E and LOP supplemented with omega-3 fatty acid and vitamin E. Preeclampsia was induced by administering l-nitroarginine methylester (l-NAME) at the dose of 50 mg/kg body weight/day. The vascular endothelial growth factor gene expression and protein levels were lower (p < 0.01 for both) in animals from both EOP as well as LOP groups (p < 0.01). In the EOP group, the protein levels of VEGF receptor-1 were also lower (p < 0.01). Supplementation of omega-3 fatty acids and vitamin E to LOP improved the levels of VEGF and VEGF receptor-1 only in the LOP but not in the EOP group. In the EOP group, the gene expression of hypoxia inducible factor 1 alpha (HIF-1α) in the placenta was higher (p < 0.05) and supplementation normalized these levels. Our findings indicate that maternal supplementation of omega-3 fatty acids and vitamin E has differential effect on preeclampsia subtypes.
Similar content being viewed by others
References
Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC et al (2015) Angiogenesis in the placenta: the role of reactive oxygen species signaling. Biomed Res Int 2015:814543. https://doi.org/10.1155/2015/814543
Cerdeira AS, Karumanchi SA (2012) Angiogenic factors in preeclampsia and related disorders. Cold Spring Harbor Perspect Med 2(11):a006585. https://doi.org/10.1101/cshperspect.a006585
Rizov M, Andreeva P, Dimova I (2017) Molecular regulation and role of angiogenesis in reproduction. Taiwan J Obstet Gynecol 56(2):127–132. https://doi.org/10.1016/j.tjog.2016.06.019
Chen DB, Zheng J (2014) Regulation of placental angiogenesis. Microcirculation 21(1):15–25. https://doi.org/10.1111/micc.12093
Gomathy E, Akurati L, Radhika K (2018) Early onset and late onset preeclampsia-maternal and perinatal outcomes in a rural teritiary health center. Int J Reprod Contracept Obstet Gynecol 7(6):2266–2269
Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B (2003) The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 189:1173–1177
Sebire NJ, Goldin RD, Regan L (2005) Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol 25:117–118. https://doi.org/10.1080/014436105400041396
Van der Merwe JL, Hall DR, Wright C, Schubert P, Grove D (2010) Are early and late preeclampsia distinct subclasses of the disease—what does the placenta reveal? Hypertens Pregnancy 29:457–467. https://doi.org/10.3109/10641950903572282
Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP et al (2011) Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 39:641–652. https://doi.org/10.1515/JPM.2011.098
Nikuei P, Malekzadeh K, Rajaei M, Nejatizadeh A, Ghasemi N (2015) The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia. Iranian J Reprod Med 13(5):251–262
Khodzhaeva Z, Kogan E, Kholin A, Akatyeva A, Vavina O et al (2013) PP016. Relation of apoptosis, proliferation and angiogenesis in early and late onset of preeclampsia. Pregnancy Hypertens. 3(2):73. https://doi.org/10.1016/j.preghy.2013.04.044
Tal R (2012) The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod 87(6):134. https://doi.org/10.1095/biolreprod.112.102723
Zimna A, Kurpisz M (2015) Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies. Biomed Res Int. https://doi.org/10.1155/2015/549412
Green DE, Sutliff RL, Hart CM (2011) Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension? Pulm Circ 1(1):33–47
Mejía-Barradas CM, Del-Río-Navarro BE, Domínguez-López A, Campos-Rodríguez R, Martínez-Godínez MD et al (2014) The consumption of n-3 polyunsaturated fatty acids differentially modulates gene expression of peroxisome proliferator-activated receptor alpha and gamma and hypoxia-inducible factor 1 alpha in subcutaneous adipose tissue of obese adolescents. Endocrine 45(1):98–105. https://doi.org/10.1007/s12020-013-9941-y
Kulkarni AV, Mehendale SS, Yadav HR, Kilari AS, Taralekar VS et al (2010) Circulating angiogenic factors and their association with birth outcomes in preeclampsia. Hypertens Res 33(6):561–567. https://doi.org/10.1038/hr.2010.31
Kulkarni AV, Mehendale SS, Yadav HR, Joshi SR (2011) Reduced placental docosahexaenoic acid levels associated with increased levels of sFlt-1 in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 84(1–2):51–55. https://doi.org/10.1016/j.plefa.2010.09.005
Sahay AS, Patil VV, Sundrani DP, Joshi AA, Wagh GN et al (2014) A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia. Hypertens Res 37(8):753–758. https://doi.org/10.1038/hr.2014.71
Sundrani D, Khot V, Pisal H, Mehendale S, Wagh G et al (2013) Gestation dependant changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy. PLoS ONE 8(1):e54153. https://doi.org/10.1371/journal.pone.0054153
Wadhwani N, Patil V, Pisal H, Joshi A, Mehendale S et al (2014) Altered maternal proportions of long chain polyunsaturated fatty acids and their transport leads to disturbed fetal stores in preeclampsia. Prostaglandins Leukot Essent Fatty Acids (PLEFA) 91(1–2):21–30. https://doi.org/10.1016/j.plefa.2014.05.006
Mehendale S, Kilari A, Dangat K, Taralekar V, Mahadik S et al (2008) Fatty acids, antioxidants, and oxidative stress in pre-eclampsia. Int J Gynecol Obstet 100(3):234–238
Zingg JM, Azzi A, Meydani M (2015) Induction of VEGF expression by alpha-tocopherol and alpha-tocopheryl phosphate via PI3 Kγ/PKB and hTAP1/SEC14L2-mediated lipid exchange. J Cell Biochem 116(3):398–407. https://doi.org/10.1002/jcb.24988
Rani A, Wadhwani N, Chavan-Gautam P, Joshi S (2016) Altered development and function of the placental regions in preeclampsia and its association with long-chain polyunsaturated fatty acids. Dev Biol 5:582–597. https://doi.org/10.1002/wdev.238
Kemse NG, Kale AA, Joshi SR (2016) Supplementation of maternal omega-3 fatty acids to pregnancy induced hypertension Wistar rats improves IL10 and VEGF levels. Prostaglandins Leukot Essent Fatty Acids 104:25–32. https://doi.org/10.1016/j.plefa.2015.11.003
Patten AR, Fontaine CJ, Christie BR (2014) A comparison of the different animal models of fetal alcohol spectrum disorders and their use in studying complex behaviors. Front Paediatr 2:93. https://doi.org/10.3389/fped.2014.00093
Kasture V, Dalvi S, Swamy M, Kale A, Joshi S (2019) Omega-3 fatty acids differentially influences embryotoxicity in subtypes of preeclampsia. Clin Exp Hypertens. https://doi.org/10.1080/10641963.2019.1601208
Nandi A, Wadhwani N, Joshi SR (2019) Vitamin D deficiency influences fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 140:57–63. https://doi.org/10.1016/j.plefa.2018.11.014
Kemse NG, Kale AA, Joshi SR (2014) A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension. PLoS ONE 9(11):e111902. https://doi.org/10.1371/journal.pone.0111902
Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, Sibai BM (2000) Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 183(6):1554–1557
Salimi S, Yaghmaei M, Tabatabaei E, Mokhtari M, Naghavi A (2015) Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level. J Obstet Gynaecol Res 41(12):1877–1883. https://doi.org/10.1111/jog.12825
Cirpan T, Akercan F, Terek MC et al (2007) Evaluation of VEGF in placental bed biopsies from preeclamptic women by immunohistochemistry. Clin Exp Obstet Gynecol 34(4):228–231
Romero R, Nien JK, Espinoza J, Todem D, Fu W et al (2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 21:9–23. https://doi.org/10.1080/14767050701830480
Purwosunu Y, Sekizawa A, Yoshimura S, Farina A, Wibowo N et al (2009) Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women. Reprod Sci 16(9):857–864. https://doi.org/10.1177/1933719109336622
Andraweera PH, Dekker GA, Roberts CT (2012) The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update 4:436–457. https://doi.org/10.1093/humupd/dms011
Akercan F, Cirpan T, Terek MC, Ozcakir HT, Giray G et al (2008) The immunohistochemical evaluation of VEGF in placenta biopsies of pregnancies complicated by preeclampsia. Arch Gynecol Obstet 277(2):109–114
Miyazawa T, Tsuzuki T, Nakagawa K, Igarashi M (2004) Antiangiogenic potency of vitamin E. Ann N Y Acad Sci 1031(1):401–404
Johnsen GM, Basak S, Weedon-Fekjaer MS, Staff AC, Duttaroy AK (2011) Docosahexaenoic acid stimulates tube formation in first trimester trophoblast cells, HTR8/SVneo. Placenta 32(9):626–632. https://doi.org/10.1016/j.placenta.2011.06.009
Kasimanickam RK, Kasimanickam VR, Rodriguez JS, Pelzer KD, Sponenberg PD et al (2010) Tocopherol induced angiogenesis in placental vascular network in late pregnant ewes. Reprod Biol Endocrinol 8:86. https://doi.org/10.1186/1477-7827-8-86
Shibuya M (2011) Involvement of Flt-1 (VEGFR-1) in cancer and preeclampsia. Proc Jpn Acad Ser B 87:167–178
Shibuya M (2013) VEGFR and type-V RTK activation and signaling. Cold Spring Harbor Perspect Biol 5(10):a009092. https://doi.org/10.1101/cshperspect.a009092
Figueira RL, Gonçalves FL, Prado AR, Ribeiro MC, Costa KM et al (2018) Ventilation-induced changes correlate to pulmonary vascular response and VEGF, VEGFR-1/2, and eNOS expression in the rat model of postnatal hypoxia. Braz J Med Biol Res 51(11):e7169. https://doi.org/10.1590/1414-431X20187169
Herraiz I, Simón E, Gómez-Arriaga PI, Quezada MS, García-Burguillo A et al (2018) Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: a prospective cohort study. Pregnancy Hypertens 13:279–285. https://doi.org/10.1016/j.preghy.2018.06.017
Akhilesh M, Mahalingam V, Nalliah S, Ali RM, Ganesalingam M et al (2014) Participation of hypoxia-inducible factor-1α in the pathogenesis of preeclampsia-related placental ischemia and its potential as a marker for preeclampsia. Biomark Genomic Med 6(3):121–125
Fujii T, Nagamatsu T, Morita K, Schust DJ, Iriyama T et al (2017) Enhanced HIF2α expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor. Sci Rep 7(1):12455. https://doi.org/10.1038/s41598-017-12685-w
Wang S, Wang X, Weng Z, Zhang S, Ning H et al (2017) Expression and role of microRNA 18b and hypoxia inducible factor-1α in placental tissues of preeclampsia patients. Exp Ther Med 14(5):4554–4560. https://doi.org/10.3892/etm.2017.5067
Iriyama T, Wang W, Parchim NF, Song A, Blackwell SC et al (2015) Hypoxia-independent upregulation of placental hypoxia inducible factor-1α gene expression contributes to the pathogenesis of preeclampsia. Hypertension 65(6):1307–1315. https://doi.org/10.1161/hypertensionaha.115.05314
Liu Y, Beyer A, Aebersold R (2016) On the dependency of cellular protein levels on mRNA abundance. Cell 165(3):535–550. https://doi.org/10.1016/j.cell.2016.03.014
Wendling O, Chambon P, Mark M (1999) Retinoid X receptors are essential for early mouse development and placentogenesis. Proc Natl Acad Sci USA 96(2):547–551
Barak Y, Liao D, He W, Ong ES, Nelson MC et al (2002) Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 99(1):303–308
Waite LL, Louie RE, Taylor RN (2005) Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab 90(2):620–626
Rodie VA, Young A, Jordan F, Sattar N, Greer IA, Freeman DJ (2005) Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig 12:320–329
Holdsworth-Carson SJ, Lim R, Mitton A, Whitehead C, Rice GE et al (2010) Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 31(3):222–229. https://doi.org/10.1016/j.placenta.2009
Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F (1997) Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes 21(8):637–643
Kaplins’kyĭ SP, Shysh AM, Nahibin VS, Dosenko V, Klimashevs’kyĭ VM et al (2009) Omega-3 polyunsaturated fatty acids stimulate the expression of PPAR target genes. Fiziolohichnyi zhurnal 55(2):37–43
Wikström AK (2007) Biochemical and epidemiological studies of early-onset and late-onset pre-eclampsia. Dissertation. Acta Universitatis Upsaliensis
Allen RE, Rogozinska E, Cleverly K, Aquilina J, Thangaratinam S (2014) Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 182:194–201. https://doi.org/10.1016/j.ejogrb.2014.09.027
Funding
Financial support from the Indian Council of Medical Research (ICMR), New Delhi, India (Grant no. 5/7/1069/13-RCH) is gratefully acknowledged. One of the authors (VK) received a fellowship from the Department of Science and Technology, Government of India (INSPIRE fellowship).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kasture, V., Sundrani, D., Dalvi, S. et al. Maternal omega-3 fatty acids and vitamin E improve placental angiogenesis in late-onset but not early-onset preeclampsia. Mol Cell Biochem 461, 159–170 (2019). https://doi.org/10.1007/s11010-019-03599-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-019-03599-4